查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1401969

荷爾蒙替代療法市場至2030年的預測：按治療類型、給藥途徑、適應症、配銷通路和地區進行的全球分析

Hormone Replacement Therapy Market Forecasts to 2030 - Global Analysis By Therapy Type, By Route of Administration, Indication, Distribution Channel and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的資料，2023年全球荷爾蒙替代療法市場規模將達到 358 億美元，預計2030年將達到 621 億美元，預測期內年複合成長率為 8.2%。

荷爾蒙替代療法（HRT）是一種醫療程序，目的是為因老齡化、更年期或其他疾病而荷爾蒙平衡受到破壞的人補充或替代雌激素、黃體酮和睪固酮等荷爾蒙。荷爾蒙替代療法可以緩解女性的潮熱、情緒低落和陰道乾燥等症狀，也可以解決男性的荷爾蒙缺乏問題。

根據世界衛生組織（WHO）預測，到2030年，全球整體六分之一的人口將超過60歲，到2050年，預計老年人口將達到21億。

各種荷爾蒙失調的盛行率不斷增加

各種荷爾蒙失調的盛行率不斷增加是荷爾蒙替代療法市場的關鍵促進因素。人口老化，生活方式的改變和環境影響等因素導致荷爾蒙失衡，女性更年期相關症狀和男性更年期的發生率增加。甲狀腺機能低下症、更年期和激素缺乏等疾病推動對荷爾蒙替代療法的需求。越來越多的患者尋求緩解與荷爾蒙失調相關的症狀和併發症，推動了荷爾蒙替代療法市場的成長。

荷爾蒙替代療法高成本

荷爾蒙替代治療藥物、諮詢和後續觀察的費用可能很高，影響了許多患者的經濟負擔。此外，保險範圍和償付限制通常會導致自付費用並限制可及性。這些財務障礙可能會阻止人們尋求或繼續荷爾蒙替代療法，影響治療醫囑遵從性和整體市場成長。

透過新的輸送系統增加藥物開發

創新的給藥方法，如經皮吸收貼片、皮下植入和生物分解性的微球，提高了治療效果、病患依從性和便利性。與傳統口服製劑相比，這些進步導致給藥更精確，荷爾蒙釋放更穩定，副作用更少。此外，透過改善治療結果並滿足尋求荷爾蒙替代療法的個人的多樣化需求，吸引患者，擴大治療選擇並推動市場成長。

治療的副作用

荷爾蒙療法，尤其是雌激素療法，會增加血栓、中風、乳癌和心血管併發症的風險。這些風險因年齡、給藥、治療持續時間和個人健康史等因素而異。對這些副作用的擔憂導致了 HRT 使用量的下降以及對其長期安全性的質疑，影響了市場成長。

COVID-19 的影響：

COVID-19 大流行對市場產生了各種影響。醫療保健服務中斷，包括前往診所的機會有限和選擇性手術減少，影響了 HRT 處方和患者諮詢。由於健康問題加劇，推遲了接受荷爾蒙治療。然而，大流行期間對更年期症狀和心理健康問題的認知提高可能推動了對荷爾蒙替代療法的需求。

預測期內，更年期族群預計將是最大的

預計更年期細分市場將成為預測期內最大的細分市場。隨著人口老化，更多女性將進入閉經並尋求治療方法來控制更年期症狀，如潮熱、盜汗和情緒變化。此外，針對更年期症狀的荷爾蒙替代療法配方和給藥方法的進步也促進了這一領域的發展。

人體生長荷爾蒙替代療法預計在預測期內年複合成長率最高

在預測期內，由於人們對生長激素缺乏症的認知不斷提高，以及成人和兒童荷爾蒙失衡發生率的增加，人體生長荷爾蒙（HGH）替代療法領域將保持強勁，預計將推動對HGH 療法的需求成長。此外，生物技術的重大發展導致了創新 HGH 配方和輸送方法的開發，以及在解決各種健康狀況方面的不斷擴大的應用，是預測該領域顯著成長的關鍵因素。

佔比最大的地區：

由於其先進的醫療基礎設施，高昂的醫療成本以及對研發的重視，預計北美將佔據最大的市場佔有率。此外，荷爾蒙失衡的普遍存在以及尋求荷爾蒙治療的人口老化也促進了市場的顯著成長。有利的償付政策和主要市場參與者的存在進一步強化了北美市場的主導地位。

年複合成長率最高的地區：

由於人口老化以及人們對更年期症狀和荷爾蒙失調的認知不斷增強，預計亞太地區的市場將出現強勁成長。此外，快速的都市化，生活方式的改變和日益成長的醫療保健問題日益增加荷爾蒙失衡的盛行率，促進市場成長。此外，醫療基礎設施的改善、可支配收入的增加以及不斷發展的法規結構促進更便利的醫療服務，推動亞太地區的大幅成長。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多3家公司）
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球荷爾蒙替代療法市場：依治療類型

  • 雌激素替代療法
  • 人體生長荷爾蒙替代療法
  • 雌激素替代療法
  • 副甲狀腺素替代療法
  • 黃體素替代療法
  • 睪固酮荷爾蒙替代療法
  • 甲狀腺激素替代療法
  • 其他治療方法

第6章 全球荷爾蒙替代療法市場：依給藥途徑

  • 口服
  • 胃腸外
  • 經皮
  • 其他給藥途徑

第7章 全球荷爾蒙替代療法市場：依適應症分類

  • 閉經
  • 生長激素缺乏症
  • 甲狀腺機能低下症
  • 男性性腺功能減退症
  • 其他適應症

第8章 全球荷爾蒙替代療法市場：依配銷通路

  • 零售藥局和藥局
  • 網路藥房
  • 其他配銷通路

第9章 全球荷爾蒙替代療法市場：依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司簡介

  • AbbVie Inc.
  • Acerus Pharmaceuticals
  • Amgen
  • Bausch Health Companies
  • Bayer AG
  • Eli Lilly and Company
  • Merck & Co.
  • Mithra Pharmaceuticals SA
  • Mylan NV
  • Novartis AG
  • Novo Nordisk
  • Pfizer Inc.
  • QuatRx Pharmaceuticals
  • Radius Health
  • Sanofi
  • Serum Institute of India
  • Teva Pharmaceutical Industries
  • TherapeuticsMD
  • Veru Inc.
Product Code: SMRC24489

According to Stratistics MRC, the Global Hormone Replacement Therapy Market is accounted for $35.8 billion in 2023 and is expected to reach $62.1 billion by 2030 growing at a CAGR of 8.2% during the forecast period. Hormone Replacement Therapy (HRT) involves medical treatments aimed at supplementing or replacing hormones, such as estrogen, progesterone, or testosterone, in individuals experiencing hormonal imbalances due to aging, menopause, or other conditions. HRT can alleviate symptoms like hot flashes, mood swings, and vaginal dryness in women and address hormonal deficiencies in men.

According to World Health Organization (WHO), it is estimated that by 2030, 1 in 6 people will be aged 60 years or more globally and by 2050, the geriatric population is expected to reach 2.1 billion worldwide.

Market Dynamics:

Driver:

Growing prevalence of various hormonal disorders

The increasing prevalence of diverse hormonal disorders serves as a significant driver in the hormone replacement therapy market. Factors such as aging populations, lifestyle changes, and environmental influences contribute to rising incidences of hormonal imbalances, menopause-related symptoms in women and andropause in men. Conditions like hypothyroidism, menopausal symptoms and hormonal deficiencies drive the demand for HRT. This growing patient pool seeking relief from symptoms and complications associated with hormonal disorders fuels the expansion of the hormone replacement therapy market.

Restraint:

High cost of hormone replacement therapy

Expenses for hormone replacement therapy medications, consultations and follow-up visits can be substantial, impacting affordability for many patients. Moreover, insurance coverage and reimbursement limitations often lead to out-of-pocket expenses, limiting accessibility. This financial barrier can deter individuals from seeking or continuing hormone replacement therapy, affecting treatment adherence and overall market growth.

Opportunity:

Rise in drug development with novel delivery systems

Innovative delivery methods, such as transdermal patches, subcutaneous implants and biodegradable microspheres, enhance treatment efficacy, patient compliance and convenience. These advancements offer precise dosing, steady hormone release and reduced side effects compared to traditional oral formulations. They also attract patient interest and expand treatment options, driving market growth by improving therapeutic outcomes and addressing the diverse needs of individuals seeking hormone replacement therapies.

Threat:

Adverse effects of therapies

Hormone therapies, particularly estrogen-based ones, may elevate the risk of blood clots, stroke, breast cancer and cardiovascular complications. These risks vary based on factors like age, dosage, duration of therapy, and individual health history. Concerns about these adverse effects have led to a decline in HRT usage and raised questions about its long-term safety, impacting market growth.

COVID-19 Impact:

The COVID-19 pandemic had varied impacts on the market. Disruptions in healthcare services, including limited access to clinics and reduced elective procedures, affected HRT prescriptions and patient consultations. Heightened health concerns led to delays in seeking hormonal therapies. However, increased awareness of menopausal symptoms and mental health issues during the pandemic might have driven demand for HRT.

The menopause segment is expected to be the largest during the forecast period

During the forecast period, the menopause segment is anticipated to become the largest in the market. As the population ages, the number of women entering menopause increases, leading to a larger demographic seeking therapies to manage menopausal symptoms like hot flashes, night sweats, and mood changes. Additionally, advancements in HRT formulations and delivery methods tailored specifically for menopausal symptoms contribute to the growth of this segment.

The human growth hormone replacement therapy segment is expected to have the highest CAGR during the forecast period

During the forecast period, the human growth hormone (HGH) replacement therapy segment is anticipated to experience robust growth owing to increased awareness of growth hormone deficiencies, coupled with rising instances of hormonal imbalances in adults and children, which is driving demand for HGH therapies. In addition, advancements in biotechnology, leading to the development of innovative HGH formulations and delivery methods, along with expanding applications in addressing various health conditions, are key contributors to the projected substantial growth in this segment.

Region with largest share:

North America is expected to witness the largest market share, due to the advanced healthcare infrastructure, high healthcare expenditure, and a significant emphasis on research and development. Moreover, the prevalence of hormonal imbalances, coupled with an aging population seeking hormone therapies, contributes to substantial market growth. Favorable reimbursement policies and the presence of key market players further reinforce North America's dominance in the market.

Region with highest CAGR:

Asia Pacific is poised for robust growth in the market due to the region's expanding aging population, coupled with increasing awareness of menopausal symptoms and hormonal disorders. Additionally, rapid urbanization, lifestyle changes, and a growing focus on healthcare have heightened the prevalence of hormonal imbalances, propelling market growth. Moreover, improving healthcare infrastructure, rising disposable incomes and evolving regulatory frameworks are facilitating greater accessibility to fostering substantial growth in the Asia Pacific region.

Key players in the market:

Some of the key players in Hormone Replacement Therapy Market include AbbVie Inc., Acerus Pharmaceuticals, Amgen, Bausch Health Companies, Bayer AG, Eli Lilly and Company, Merck & Co., Mithra Pharmaceuticals SA, Mylan NV, Novartis AG, Novo Nordisk, Pfizer Inc., QuatRx Pharmaceuticals, Radius Health, Sanofi, Serum Institute of India, Teva Pharmaceutical Industries, TherapeuticsMD and Veru Inc.

Key Developments:

In August 2022, Akorn announced that it had successfully received FDA approval for launching its Generic-Cetrorelix Acetate in the form of Injection (0.25 mg quantity). Cetrorelix is one of the most effective chemicals used in hormone replacement therapy as it totally blocks the adverse impacts of a natural hormone, known as GnRH or gonadotropin-releasing hormone.

In February 2022, MHLW of Japan approved NGENLA of Pfizer, Inc. and OPKO which is a long-lasting treatment for pediatric growth hormone deficiency. This strategic initiative helps the companies to expand their customer base in different geography and boost their revenue.

Therapy Types Covered:

  • Estrogen Hormone Replacement Therapy
  • Human Growth Hormone Replacement Therapy
  • Oestrogen Hormone Replacement Therapy
  • Parathyroid Hormone Replacement Therapy
  • Progestogen Hormone Replacement Therapy
  • Testosterone Hormone Replacement Therapy
  • Thyroid Hormone Replacement Therapy
  • Other Therapy Types

Route of Administrations Covered:

  • Oral
  • Parenteral
  • Transdermal
  • Other Route of Administrations

Indications Covered:

  • Menopause
  • Growth Hormone Deficiency
  • Hypothyroidism
  • Male Hypogonadism
  • Other Indications

Distribution Channels Covered:

  • Retail Pharmacies and Drugstores
  • Online Pharmacies
  • Other Distribution Channels

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Emerging Markets
  • 3.7 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Hormone Replacement Therapy Market, By Therapy Type

  • 5.1 Introduction
  • 5.2 Estrogen Hormone Replacement Therapy
  • 5.3 Human Growth Hormone Replacement Therapy
  • 5.4 Oestrogen Hormone Replacement Therapy
  • 5.5 Parathyroid Hormone Replacement Therapy
  • 5.6 Progestogen Hormone Replacement Therapy
  • 5.7 Testosterone Hormone Replacement Therapy
  • 5.8 Thyroid Hormone Replacement Therapy
  • 5.9 Other Therapy Types

6 Global Hormone Replacement Therapy Market, By Route of Administration

  • 6.1 Introduction
  • 6.2 Oral
  • 6.3 Parenteral
  • 6.4 Transdermal
  • 6.5 Other Route of Administrations

7 Global Hormone Replacement Therapy Market, By Indication

  • 7.1 Introduction
  • 7.2 Menopause
  • 7.3 Growth Hormone Deficiency
  • 7.4 Hypothyroidism
  • 7.5 Male Hypogonadism
  • 7.6 Other Indications

8 Global Hormone Replacement Therapy Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Retail Pharmacies and Drugstores
  • 8.3 Online Pharmacies
  • 8.4 Other Distribution Channels

9 Global Hormone Replacement Therapy Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 AbbVie Inc.
  • 11.2 Acerus Pharmaceuticals
  • 11.3 Amgen
  • 11.4 Bausch Health Companies
  • 11.5 Bayer AG
  • 11.6 Eli Lilly and Company
  • 11.7 Merck & Co.
  • 11.8 Mithra Pharmaceuticals SA
  • 11.9 Mylan NV
  • 11.10 Novartis AG
  • 11.11 Novo Nordisk
  • 11.12 Pfizer Inc.
  • 11.13 QuatRx Pharmaceuticals
  • 11.14 Radius Health
  • 11.15 Sanofi
  • 11.16 Serum Institute of India
  • 11.17 Teva Pharmaceutical Industries
  • 11.18 TherapeuticsMD
  • 11.19 Veru Inc.

List of Tables

  • Table 1 Global Hormone Replacement Therapy Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Hormone Replacement Therapy Market Outlook, By Therapy Type (2021-2030) ($MN)
  • Table 3 Global Hormone Replacement Therapy Market Outlook, By Estrogen Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 4 Global Hormone Replacement Therapy Market Outlook, By Human Growth Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 5 Global Hormone Replacement Therapy Market Outlook, By Oestrogen Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 6 Global Hormone Replacement Therapy Market Outlook, By Parathyroid Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 7 Global Hormone Replacement Therapy Market Outlook, By Progestogen Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 8 Global Hormone Replacement Therapy Market Outlook, By Testosterone Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 9 Global Hormone Replacement Therapy Market Outlook, By Thyroid Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 10 Global Hormone Replacement Therapy Market Outlook, By Other Therapy Types (2021-2030) ($MN)
  • Table 11 Global Hormone Replacement Therapy Market Outlook, By Route of Administration (2021-2030) ($MN)
  • Table 12 Global Hormone Replacement Therapy Market Outlook, By Oral (2021-2030) ($MN)
  • Table 13 Global Hormone Replacement Therapy Market Outlook, By Parenteral (2021-2030) ($MN)
  • Table 14 Global Hormone Replacement Therapy Market Outlook, By Transdermal (2021-2030) ($MN)
  • Table 15 Global Hormone Replacement Therapy Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
  • Table 16 Global Hormone Replacement Therapy Market Outlook, By Indication (2021-2030) ($MN)
  • Table 17 Global Hormone Replacement Therapy Market Outlook, By Menopause (2021-2030) ($MN)
  • Table 18 Global Hormone Replacement Therapy Market Outlook, By Growth Hormone Deficiency (2021-2030) ($MN)
  • Table 19 Global Hormone Replacement Therapy Market Outlook, By Hypothyroidism (2021-2030) ($MN)
  • Table 20 Global Hormone Replacement Therapy Market Outlook, By Male Hypogonadism (2021-2030) ($MN)
  • Table 21 Global Hormone Replacement Therapy Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 22 Global Hormone Replacement Therapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 23 Global Hormone Replacement Therapy Market Outlook, By Retail Pharmacies and Drugstores (2021-2030) ($MN)
  • Table 24 Global Hormone Replacement Therapy Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 25 Global Hormone Replacement Therapy Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 26 North America Hormone Replacement Therapy Market Outlook, By Country (2021-2030) ($MN)
  • Table 27 North America Hormone Replacement Therapy Market Outlook, By Product (2021-2030) ($MN)
  • Table 28 North America Hormone Replacement Therapy Market Outlook, By Therapy Type (2021-2030) ($MN)
  • Table 29 North America Hormone Replacement Therapy Market Outlook, By Estrogen Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 30 North America Hormone Replacement Therapy Market Outlook, By Human Growth Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 31 North America Hormone Replacement Therapy Market Outlook, By Oestrogen Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 32 North America Hormone Replacement Therapy Market Outlook, By Parathyroid Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 33 North America Hormone Replacement Therapy Market Outlook, By Progestogen Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 34 North America Hormone Replacement Therapy Market Outlook, By Testosterone Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 35 North America Hormone Replacement Therapy Market Outlook, By Thyroid Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 36 North America Hormone Replacement Therapy Market Outlook, By Other Therapy Types (2021-2030) ($MN)
  • Table 37 North America Hormone Replacement Therapy Market Outlook, By Route of Administration (2021-2030) ($MN)
  • Table 38 North America Hormone Replacement Therapy Market Outlook, By Oral (2021-2030) ($MN)
  • Table 39 North America Hormone Replacement Therapy Market Outlook, By Parenteral (2021-2030) ($MN)
  • Table 40 North America Hormone Replacement Therapy Market Outlook, By Transdermal (2021-2030) ($MN)
  • Table 41 North America Hormone Replacement Therapy Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
  • Table 42 North America Hormone Replacement Therapy Market Outlook, By Indication (2021-2030) ($MN)
  • Table 43 North America Hormone Replacement Therapy Market Outlook, By Menopause (2021-2030) ($MN)
  • Table 44 North America Hormone Replacement Therapy Market Outlook, By Growth Hormone Deficiency (2021-2030) ($MN)
  • Table 45 North America Hormone Replacement Therapy Market Outlook, By Hypothyroidism (2021-2030) ($MN)
  • Table 46 North America Hormone Replacement Therapy Market Outlook, By Male Hypogonadism (2021-2030) ($MN)
  • Table 47 North America Hormone Replacement Therapy Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 48 North America Hormone Replacement Therapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 49 North America Hormone Replacement Therapy Market Outlook, By Retail Pharmacies and Drugstores (2021-2030) ($MN)
  • Table 50 North America Hormone Replacement Therapy Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 51 North America Hormone Replacement Therapy Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 52 Europe Hormone Replacement Therapy Market Outlook, By Country (2021-2030) ($MN)
  • Table 53 Europe Hormone Replacement Therapy Market Outlook, By Product (2021-2030) ($MN)
  • Table 54 Europe Hormone Replacement Therapy Market Outlook, By Therapy Type (2021-2030) ($MN)
  • Table 55 Europe Hormone Replacement Therapy Market Outlook, By Estrogen Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 56 Europe Hormone Replacement Therapy Market Outlook, By Human Growth Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 57 Europe Hormone Replacement Therapy Market Outlook, By Oestrogen Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 58 Europe Hormone Replacement Therapy Market Outlook, By Parathyroid Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 59 Europe Hormone Replacement Therapy Market Outlook, By Progestogen Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 60 Europe Hormone Replacement Therapy Market Outlook, By Testosterone Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 61 Europe Hormone Replacement Therapy Market Outlook, By Thyroid Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 62 Europe Hormone Replacement Therapy Market Outlook, By Other Therapy Types (2021-2030) ($MN)
  • Table 63 Europe Hormone Replacement Therapy Market Outlook, By Route of Administration (2021-2030) ($MN)
  • Table 64 Europe Hormone Replacement Therapy Market Outlook, By Oral (2021-2030) ($MN)
  • Table 65 Europe Hormone Replacement Therapy Market Outlook, By Parenteral (2021-2030) ($MN)
  • Table 66 Europe Hormone Replacement Therapy Market Outlook, By Transdermal (2021-2030) ($MN)
  • Table 67 Europe Hormone Replacement Therapy Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
  • Table 68 Europe Hormone Replacement Therapy Market Outlook, By Indication (2021-2030) ($MN)
  • Table 69 Europe Hormone Replacement Therapy Market Outlook, By Menopause (2021-2030) ($MN)
  • Table 70 Europe Hormone Replacement Therapy Market Outlook, By Growth Hormone Deficiency (2021-2030) ($MN)
  • Table 71 Europe Hormone Replacement Therapy Market Outlook, By Hypothyroidism (2021-2030) ($MN)
  • Table 72 Europe Hormone Replacement Therapy Market Outlook, By Male Hypogonadism (2021-2030) ($MN)
  • Table 73 Europe Hormone Replacement Therapy Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 74 Europe Hormone Replacement Therapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 75 Europe Hormone Replacement Therapy Market Outlook, By Retail Pharmacies and Drugstores (2021-2030) ($MN)
  • Table 76 Europe Hormone Replacement Therapy Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 77 Europe Hormone Replacement Therapy Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 78 Asia Pacific Hormone Replacement Therapy Market Outlook, By Country (2021-2030) ($MN)
  • Table 79 Asia Pacific Hormone Replacement Therapy Market Outlook, By Product (2021-2030) ($MN)
  • Table 80 Asia Pacific Hormone Replacement Therapy Market Outlook, By Therapy Type (2021-2030) ($MN)
  • Table 81 Asia Pacific Hormone Replacement Therapy Market Outlook, By Estrogen Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 82 Asia Pacific Hormone Replacement Therapy Market Outlook, By Human Growth Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 83 Asia Pacific Hormone Replacement Therapy Market Outlook, By Oestrogen Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 84 Asia Pacific Hormone Replacement Therapy Market Outlook, By Parathyroid Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 85 Asia Pacific Hormone Replacement Therapy Market Outlook, By Progestogen Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 86 Asia Pacific Hormone Replacement Therapy Market Outlook, By Testosterone Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 87 Asia Pacific Hormone Replacement Therapy Market Outlook, By Thyroid Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 88 Asia Pacific Hormone Replacement Therapy Market Outlook, By Other Therapy Types (2021-2030) ($MN)
  • Table 89 Asia Pacific Hormone Replacement Therapy Market Outlook, By Route of Administration (2021-2030) ($MN)
  • Table 90 Asia Pacific Hormone Replacement Therapy Market Outlook, By Oral (2021-2030) ($MN)
  • Table 91 Asia Pacific Hormone Replacement Therapy Market Outlook, By Parenteral (2021-2030) ($MN)
  • Table 92 Asia Pacific Hormone Replacement Therapy Market Outlook, By Transdermal (2021-2030) ($MN)
  • Table 93 Asia Pacific Hormone Replacement Therapy Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
  • Table 94 Asia Pacific Hormone Replacement Therapy Market Outlook, By Indication (2021-2030) ($MN)
  • Table 95 Asia Pacific Hormone Replacement Therapy Market Outlook, By Menopause (2021-2030) ($MN)
  • Table 96 Asia Pacific Hormone Replacement Therapy Market Outlook, By Growth Hormone Deficiency (2021-2030) ($MN)
  • Table 97 Asia Pacific Hormone Replacement Therapy Market Outlook, By Hypothyroidism (2021-2030) ($MN)
  • Table 98 Asia Pacific Hormone Replacement Therapy Market Outlook, By Male Hypogonadism (2021-2030) ($MN)
  • Table 99 Asia Pacific Hormone Replacement Therapy Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 100 Asia Pacific Hormone Replacement Therapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 101 Asia Pacific Hormone Replacement Therapy Market Outlook, By Retail Pharmacies and Drugstores (2021-2030) ($MN)
  • Table 102 Asia Pacific Hormone Replacement Therapy Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 103 Asia Pacific Hormone Replacement Therapy Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 104 South America Hormone Replacement Therapy Market Outlook, By Country (2021-2030) ($MN)
  • Table 105 South America Hormone Replacement Therapy Market Outlook, By Product (2021-2030) ($MN)
  • Table 106 South America Hormone Replacement Therapy Market Outlook, By Therapy Type (2021-2030) ($MN)
  • Table 107 South America Hormone Replacement Therapy Market Outlook, By Estrogen Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 108 South America Hormone Replacement Therapy Market Outlook, By Human Growth Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 109 South America Hormone Replacement Therapy Market Outlook, By Oestrogen Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 110 South America Hormone Replacement Therapy Market Outlook, By Parathyroid Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 111 South America Hormone Replacement Therapy Market Outlook, By Progestogen Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 112 South America Hormone Replacement Therapy Market Outlook, By Testosterone Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 113 South America Hormone Replacement Therapy Market Outlook, By Thyroid Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 114 South America Hormone Replacement Therapy Market Outlook, By Other Therapy Types (2021-2030) ($MN)
  • Table 115 South America Hormone Replacement Therapy Market Outlook, By Route of Administration (2021-2030) ($MN)
  • Table 116 South America Hormone Replacement Therapy Market Outlook, By Oral (2021-2030) ($MN)
  • Table 117 South America Hormone Replacement Therapy Market Outlook, By Parenteral (2021-2030) ($MN)
  • Table 118 South America Hormone Replacement Therapy Market Outlook, By Transdermal (2021-2030) ($MN)
  • Table 119 South America Hormone Replacement Therapy Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
  • Table 120 South America Hormone Replacement Therapy Market Outlook, By Indication (2021-2030) ($MN)
  • Table 121 South America Hormone Replacement Therapy Market Outlook, By Menopause (2021-2030) ($MN)
  • Table 122 South America Hormone Replacement Therapy Market Outlook, By Growth Hormone Deficiency (2021-2030) ($MN)
  • Table 123 South America Hormone Replacement Therapy Market Outlook, By Hypothyroidism (2021-2030) ($MN)
  • Table 124 South America Hormone Replacement Therapy Market Outlook, By Male Hypogonadism (2021-2030) ($MN)
  • Table 125 South America Hormone Replacement Therapy Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 126 South America Hormone Replacement Therapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 127 South America Hormone Replacement Therapy Market Outlook, By Retail Pharmacies and Drugstores (2021-2030) ($MN)
  • Table 128 South America Hormone Replacement Therapy Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 129 South America Hormone Replacement Therapy Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 130 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Country (2021-2030) ($MN)
  • Table 131 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Product (2021-2030) ($MN)
  • Table 132 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Therapy Type (2021-2030) ($MN)
  • Table 133 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Estrogen Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 134 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Human Growth Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 135 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Oestrogen Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 136 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Parathyroid Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 137 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Progestogen Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 138 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Testosterone Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 139 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Thyroid Hormone Replacement Therapy (2021-2030) ($MN)
  • Table 140 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Other Therapy Types (2021-2030) ($MN)
  • Table 141 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Route of Administration (2021-2030) ($MN)
  • Table 142 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Oral (2021-2030) ($MN)
  • Table 143 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Parenteral (2021-2030) ($MN)
  • Table 144 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Transdermal (2021-2030) ($MN)
  • Table 145 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
  • Table 146 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Indication (2021-2030) ($MN)
  • Table 147 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Menopause (2021-2030) ($MN)
  • Table 148 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Growth Hormone Deficiency (2021-2030) ($MN)
  • Table 149 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Hypothyroidism (2021-2030) ($MN)
  • Table 150 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Male Hypogonadism (2021-2030) ($MN)
  • Table 151 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 152 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 153 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Retail Pharmacies and Drugstores (2021-2030) ($MN)
  • Table 154 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 155 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Other Distribution Channels (2021-2030) ($MN)